European Journal of Nuclear Medicine and Molecular Imaging Q1 Unclaimed
Highly ranked among journals in its field, the European Journal of Nuclear Medicine and Molecular Imaging provides a forum for the exchange of clinical and scientific information for the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease.The journal remains of primary interest to practitioners in the field of nuclear medicine but also reports on original work relating to physics, dosimetry, radiation biology, radiochemistry and pharmacy. Original material examines the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies. The Journal publishes in-depth reviews of topical interest, short communications, controversies, interesting images and letters to the Editor. This is the official journal of the European Association of Nuclear Medicine (EANM). EANM members are entitled to access the full-text electronic version of the journal via the society's website www.eanm.org in the restricted members' area.Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with the journals EJNMMI Physics, EJNMMI Research, EJNMMI Radiopharmacy and Chemistry, and the European Journal of Hybrid Imaging.EJNMMI is part of the EJNMMI journal family. Further details can be found at https://www.springeropen.com/p/nuclear-medicine including the winners of the Annual EANM Springer Award.
Why publish with us
As Europe's leading journal in our field, we welcome international submissions from the nuclear medicine community and allied professions involved in the functional, metabolic and molecular investigation of disease.
Our coverage extends to physics, dosimetry, radiation biology, radiochemistry and pharmacy.
We offer high quality peer review by experts in the field, and our highly cited and downloaded articles help ensure global visibility for your work. It has an SJR impact factor of 2,28.
European Journal of Nuclear Medicine and Molecular Imaging focuses its scope in these topics and keywords: petct, imaging, molecular, tumor, head, tumour, treatment, emission, positron, fdopa, ...
Type: Journal
Type of Copyright:
Languages: English
Open Access Policy: Open Choice
Type of publications:
Publication frecuency: -
3690 €
Inmediate OANPD
Embargoed OA0 €
Non OAMetrics
2,28
SJR Impact factor186
H Index486
Total Docs (Last Year)1377
Total Docs (3 years)16576
Total Refs8625
Total Cites (3 years)1105
Citable Docs (3 years)6.75
Cites/Doc (2 years)34.11
Ref/DocOther journals with similar parameters
Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1
Compare this journals
Aims and Scope
Best articles by citations
Dosimetry in leakage of 188 Re-DTPA during intracoronary balloon brachytherapy
View moreAntisense imaging of epidermal growth factor-induced p21 WAF-1/CIP-1 gene expression in MDA-MB-468 human breast cancer xenografts
View moreUndergraduate teaching of nuclear medicine in European universities
View moreEuropean Journal of Nuclear Medicine and Molecular Imaging manuscript processing goes online
View moreFever of unknown origin: prospective comparison of [18F]FDG imaging with a double-head coincidence camera and gallium-67 citrate SPET
View morePET/CT: a new imaging technology in nuclear medicine
View morePET/CT: a new road map
View moreRapid normalization of osseous FDG uptake following traumatic or surgical fractures
View moreInformation transfer from the USA and Europe to Latin America: current need and suitable methods
View moreImportant developments for the European Journal of Nuclear Medicine and Molecular Imaging
View moreUnifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials
View morePractical use and implementation of PET in children in a hospital PET centre
View more[ 11 C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain
View moreIn vivo imaging of rat brain A 1 adenosine receptor occupancy by caffeine
View moreInfection imaging using whole-body FDG-PET
View moreSestamibi is a substrate for MDR1 and MDR2 P-glycoprotein genes
View moreImprovement of signal-to-noise ratio using iterative reconstruction in a 99m Tc-ECD split-dose injection protocol
View morePersistent non-specific FDG uptake on PET imaging following hip arthroplasty
View moreComparison of 16-frame and 8-frame gated SPET imaging for determination of left ventricular volumes and ejection fraction
View moreMolecular imaging and molecular diagnostics: two sides of the same coin?
View moreFDG-PET imaging in HIV-infected subjects: relation with therapy and immunovirological variables
View moreEnhanced washout of 99m Tc-tetrofosmin in hypertrophic cardiomyopathy: quantitative comparisons with regional 123 I-BMIPP uptake and wall thickness determined by MRI
View moreIn vitro evaluation of 213Bi-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage
View moreThe role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma
View more
Comments